Endocrine Disruptors in Cosmetic Products and the Regulatory Framework: Public Health Implications
Cosmetics · 24.11.2023 · 10 (6) · 160
DOI: 10.3390/cosmetics10060160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cosmetics, online erschienen am 24.11.2023. Verfasst von Paraskevi Kalofiri und 5 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endocrine disruptors (EDs) are molecules capable of mimicking the natural hormones of the body and interfering with the endocrine system in both humans and wildlife. Cosmetic products are one source of EDs; these include an extensive variety of personal care and beauty products designed for the skin and hair, as well as makeup. The widespread use of such products has raised concerns about the presence of EDs within them. In this study, we highlight the issue of EDs and analyze the functioning of the EU regulatory framework for chemicals, specifically those which act as EDs in cosmetic products. We also highlight issues related to the interface between science and policy in the critical area of risk regulation within the EU. In addition, we investigate how chemical substances that act as EDs are identified based on specific criteria and conditions, a process which involves the production and adoption of particular scientific opinions. Finally, we assess the efficiency, suitability, and effectiveness of the regulatory framework in this sensitive area of human exposure to chemicals, especially those that function as EDs.
Zitieren
APA
Kalofiri, P., Biskanaki, F., Kefala, V., Tertipi, N., Sfyri, E., & Rallis, E. (2023). Endocrine Disruptors in Cosmetic Products and the Regulatory Framework: Public Health Implications. Cosmetics, 10(6), 160. https://doi.org/10.3390/cosmetics10060160
Vancouver
Kalofiri P, Biskanaki F, Kefala V, Tertipi N, Sfyri E, Rallis E. Endocrine Disruptors in Cosmetic Products and the Regulatory Framework: Public Health Implications. Cosmetics. 2023;10(6):160. doi:10.3390/cosmetics10060160
BibTeX
@article{Kalofiri2023,
author = {Kalofiri, Paraskevi and Biskanaki, Foteini and Kefala, Vasiliki and Tertipi, Niki and Sfyri, Eleni and Rallis, Efstathios},
title = {Endocrine Disruptors in Cosmetic Products and the Regulatory Framework: Public Health Implications},
journal = {Cosmetics},
year = {2023},
volume = {10},
number = {6},
pages = {160},
doi = {10.3390/cosmetics10060160}
}
EUVIMED